New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the nonprofit.

LATE is a prevalent condition in late life and can contribute to memory loss and cognitive decline, according to report co-author Rebecca M. Edelmayer, Ph.D., Alzheimer’s Association vice president of scientific engagement in Chicago.

Huge pressure' The report from Dr Brink said the island needed to focus on preventing illnesses as well as treating them. Mrs Thompson said high low-density lipoprotein cholester

Frigid temperatures and unprecedented snowfall in various parts of the U.S. can pave the way for heightened dangers this season.

January is Alzheimer's Awareness Month in Canada. According to the Alzheimer's Association, almost 750,000 Canadians are living with Alzheimer's disease or other forms of dementia. Alzheimer's is a brain disease that causes significant problems with memory and thinking.

Alzheimer’s Association will be hosting a series of classes in Lawton but since their last announcement of classes, they have released an update on their class schedule.

A new study clams dementia cases will double by 2060. Here’s what experts believe could be driving the rise in dementia rates and what you can do to help prevent it.

People who care for patients with Alzheimer's or other dementia must be alert when winter weather turns dangerous, advises the Nebraska Alzheimer's Association.

New guidelines will help doctors identify patients with a common memory-loss syndrome that is often misdiagnosed as Alzheimer's disease in older adults. The diagnostic criteria for limbic-predominant age-related TDP-43 encephalopathy (LATE) have just been published.

Antimicrobials, vaccines, anti-inflammatories linked to reduced risk for Alzheimer disease and dementia; antipsychotics and diabetes drugs tied to higher risk

Alzheimer’s and aging advocates will be at the Arizona Capitol asking lawmakers to support a bill that would update and improve the state’s long-term care system.

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon confirm that.